Iommi, M.; Faragalli, A.; Bonifazi, M.; Mei, F.; Latini, L.L.; Pompili, M.; Carle, F.; Gesuita, R.
Prognosis and Survival in Idiopathic Pulmonary Fibrosis in the Era of Antifibrotic Therapy in Italy: Evidence from a Longitudinal Population Study Based on Healthcare Utilization Databases. Int. J. Environ. Res. Public Health 2022, 19, 16689.
https://doi.org/10.3390/ijerph192416689
AMA Style
Iommi M, Faragalli A, Bonifazi M, Mei F, Latini LL, Pompili M, Carle F, Gesuita R.
Prognosis and Survival in Idiopathic Pulmonary Fibrosis in the Era of Antifibrotic Therapy in Italy: Evidence from a Longitudinal Population Study Based on Healthcare Utilization Databases. International Journal of Environmental Research and Public Health. 2022; 19(24):16689.
https://doi.org/10.3390/ijerph192416689
Chicago/Turabian Style
Iommi, Marica, Andrea Faragalli, Martina Bonifazi, Federico Mei, Lara Letizia Latini, Marco Pompili, Flavia Carle, and Rosaria Gesuita.
2022. "Prognosis and Survival in Idiopathic Pulmonary Fibrosis in the Era of Antifibrotic Therapy in Italy: Evidence from a Longitudinal Population Study Based on Healthcare Utilization Databases" International Journal of Environmental Research and Public Health 19, no. 24: 16689.
https://doi.org/10.3390/ijerph192416689
APA Style
Iommi, M., Faragalli, A., Bonifazi, M., Mei, F., Latini, L. L., Pompili, M., Carle, F., & Gesuita, R.
(2022). Prognosis and Survival in Idiopathic Pulmonary Fibrosis in the Era of Antifibrotic Therapy in Italy: Evidence from a Longitudinal Population Study Based on Healthcare Utilization Databases. International Journal of Environmental Research and Public Health, 19(24), 16689.
https://doi.org/10.3390/ijerph192416689